Answers are grounded in this paper and cite their sources.
Importance Biomarker discovery is a key research area in psychiatry, with the goals of identifying susceptibility to conditions, improving diagnostic accuracy, and predicting treatment response. Most biomarkers in psychiatry fail to be externally validated. Objective To discuss 5 key principles used in unreliable biomarker discovery and provide alternative strategies for rigorous internal validation of biomarkers that can improve rigor and replicability. Evidence Review Six articles were reviewed for biomarker discovery in major depressive disorder and their use of the 5 principles. Findings Well-documented unreliable practices have contributed to failed biomarker research. Modern methods are subject to the same unreliable principles. Conclusions and Relevance Rigorous biomarker discovery is rare and remains a challenge with complex data augmentation, synthetic data, and cross-validation strategies.
No takes yet. Share an insight, caveat, or question.
Vandekar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: